Equity MRK
Tuesday, August 14, 2018   
Adani Ports  373.35    (-1.06%)
 
Asian Paints  1395.55    (-0.20%)
 
Axis Bank  618.30    (2.15%)
 
Bajaj Auto  2645.55    (0.49%)
 
Bharti Airtel  366.50    (-0.66%)
 
Coal India  281.50    (0.81%)
 
H D F C  1941.65    (-0.23%)
 
HDFC Bank  2089.15    (-0.07%)
 
Hero Motocorp  3263.00    (-1.29%)
 
Hind. Unilever  1747.10    (0.82%)
 
ICICI Bank  332.30    (2.17%)
 
IndusInd Bank  1998.10    (0.24%)
 
Infosys  1408.75    (-0.05%)
 
ITC  307.25    (0.44%)
 
Kotak Mah. Ban...  1291.60    (0.31%)
 
Larsen & Toubr...  1253.50    (-1.19%)
 
M & M  952.05    (-0.21%)
 
Maruti Suzuki  9129.85    (0.44%)
 
NTPC  156.95    (-0.70%)
 
O N G C  166.35    (0.12%)
 
Power Grid Cor...  187.20    (-0.37%)
 
Reliance Inds.  1210.95    (2.00%)
 
St Bk of India  294.70    (-0.03%)
 
Sun Pharma.Ind...  601.65    (6.91%)
 
Tata Motors  248.70    (0.06%)
 
Tata Motors-DV...  135.40    (-0.70%)
 
Tata Steel  578.90    (1.70%)
 
TCS  2001.25    (0.04%)
 
Vedanta  215.10    (-0.44%)
 
Wipro  284.40    (0.60%)
 
Yes Bank  381.75    (2.87%)
 
Market Menu
plusminDaily Market Tracker
plusminNews
Corporate Information
Corporate Actions
Other Markets
Close
You are here : Equity | News | Corporate News
Suven Life Sciences secures Product Patents in Australia and Singapore
(10:38, 17 May 2018)
Suven Life Sciences announced the grant of two (2) product patents from Australia and one (1) product patent from Singapore corresponding to the New Chemical Entities (NCEs) for the treatment of disorders associated with Neurodegenerative diseases and these Patents are valid through 2034.

The granted claims of the patents include the class of selective H3 Inverse agonists and 5HT6 compounds respectively and are being developed as therapeutic agents for major depressive disorders and for the treatment of cognitive impairment associated with neurodegenerative disorders like Alzheimer's disease, Attention deficient hyperactivitydisorder (ADHD), Huntington's disease, Narcolepsy, Parkinson and Schizophrenia respectively.

Powered by Capital Market - Live News